Bezafibrate/Chenodeoxycholic acid

苯扎贝特/鹅去氧胆酸

Report date: 2022/01/24 09:15:23

Base Information

Drug NameBezafibrate/Chenodeoxycholic acid
Drug Alias NameBezafibrate/Chenodiol鹅去氧胆酸苯扎贝特Bezafibrate and chenodeoxycholic acid鹅去氧胆酸/苯扎贝特苯扎贝特鹅去氧胆酸 +[9] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionPeroxisome proliferator activated receptor agonistsCytochrome P450 7A1 inhibitors
TargetsPeroxisome proliferator activated receptorCytochrome P450 7A1
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes BezafibrateChenodeoxycholic acid
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGiaconda Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGiaconda Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A